β-Amyloid and the pathogenesis of alzheimer's disease

No abstract is available for this paper.

• Publication year

  1991

• Venue

  The New England Journal of Medicine

• Publication date

  1991-12-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199112263252605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• Deposits of amyloid beta protein in the central nervous system of transgenic mice.

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• Coca chewing and cholera.

  1991cited by this paper
• Formation of β-amyloid protein deposits in brains of transgenic mice

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

  1991cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid beta-protein.

  1991cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• The SEC receptor recognizes a pentapeptide neodomain of α1-antitrypsin-protease complexes

  1991cited by this paper
• Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

  1991cited by this paper
• Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor.

  1991cited by this paper
• Memory‐related neural systems in Alzheimer's disease

  1990cited by this paper
• Clipsin, a chymotrypsin-like protease in rat brain which is irreversibly inhibited by alpha-1-antichymotrypsin.

  1990cited by this paper
• Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons.

  1990cited by this paper
• Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein.

  1990cited by this paper
• Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder

  1990cited by this paper
• Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.

  1990cited by this paper
• Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Nerve growth factor potentiates the neurotoxicity of beta amyloid.

  1990cited by this paper
• Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Spontaneous neurodegeneration in transgenic mice with mutant prion protein

  1990cited by this paper
• Alz-50 recognizes a phosphorylated epitope of tau protein

  1990cited by this paper
• The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II

  1989cited by this paper
• Amyloid beta protein enhances the survival of hippocampal neurons in vitro.

  1989cited by this paper
• Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease

  1989cited by this paper
• Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome

  1989cited by this paper
• Synaptic loss in Alzheimer's disease and other dementias

  1989cited by this paper
• Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

  1989cited by this paper
• A prospective study of Alzheimer disease in Down syndrome.

  1989cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study.

  1989cited by this paper
• Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

  1989cited by this paper
• Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases.

  1989cited by this paper
• Protease nexin I immunostaining in alzheimer's disease

  1989cited by this paper
• The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome.

  1989cited by this paper
• Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.

  1989cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Familial amyloidotic polyneuropathy.

  1989cited by this paper
• Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.

  1989cited by this paper
• Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

  1989cited by this paper
• Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve Cells

  1988cited by this paper
• Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

  1988cited by this paper
• Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

  1988cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

  1988cited by this paper
• A4 amyloid protein deposition and the diagnosis of Alzheimer's disease

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

  1988cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

  1988cited by this paper
• The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.

  1988cited by this paper
• Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease.

  1988cited by this paper
• The carboxyl third of tau is tightly bound to paired helical filaments.

  1988cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper
• Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.

  1988cited by this paper
• Clinico‐pathologic studies in dementia

  1988cited by this paper
• Alz‐50 Antibody recognizes alzheimer‐related neuronal changes

  1988cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families

  1987cited by this paper
• Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease

  1987cited by this paper
• The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

  1987cited by this paper
• Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles

  1987cited by this paper
• Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

  1987cited by this paper
• Alzheimer's disease and other dementing illnesses in a defined united states population: Incidence rates and clinical features

  1987cited by this paper
• The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene

  1987cited by this paper
• Prevalence of Alzheimer's disease in a retirement community.

  1987cited by this paper
• Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

  1987cited by this paper
• Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Cholinergic drugs in Alzheimer's disease.

  1986cited by this paper
• Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

  1986cited by this paper
• New perspectives on Alzheimer's disease.

  1986cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper
• Alzheimer plaques and cortical cholinergic innervation.

  1986cited by this paper
• A neuronal antigen in the brains of Alzheimer patients.

  1986cited by this paper
• Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques.

  1986cited by this paper
• Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

  1985cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

  1985cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type

  1985cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.

  1984cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace

  1983cited by this paper
• Oral physostigmine and lecithin improve memory in Alzheimer disease

  1983cited by this paper
• Biopsy‐proved Alzheimer disease presenting as a right parietal lobe syndrome

  1982cited by this paper
• Purification of a new neurotrophic factor from mammalian brain.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Plaques, tangles and dementia. A quantitative study.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper

• Prion diseases: Lessons from historical outbreaks and potential emerging ones

  2025cites this paper
• Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression

  2025cites this paper
• Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer’s Disease

  2023cites this paper
• Effectiveness of coenzyme Q10 on learning and memory and synaptic plasticity impairment in an aged Aβ-induced rat model of Alzheimer’s disease: a behavioral, biochemical, and electrophysiological study

  2023cites this paper
• A Micronutrient Mixture with Collagen Peptides, Probiotics, Cannabidiol, and diet may Reduce Aging, and Development and Progression of Age-Related Alzheimer's Disease, and Improve its Treatment.

  2022cites this paper
• The Contribution of the Locus Coeruleus–Noradrenaline System Degeneration during the Progression of Alzheimer’s Disease

  2022cites this paper
• Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer’s Disease From the Perspective of Pathophysiological Processes

  2021cites this paper
• Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients

  2020cites this paper
• When Does Alzheimer′s Disease Really Start? | Encyclopedia

  2020cites this paper
• Heart and Brain: Complex Relationships for Left Ventricular Dysfunction

  2020cites this paper
• Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer’s Disease

  2020cites this paper
• When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

  2019cites this paper
• Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

  2019cites this paper
• Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.

  2018cites this paper
• A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

  2017cites this paper
• Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease.

  2016cites this paper
• Curcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells

  2016cites this paper
• Yeast as a platform for identification of chemo-protectors of Alzheimer's disease

  2015cites this paper
• Diffusion Tensor Imaging Reveals Visual Pathway Damage in Patients with Mild Cognitive Impairment and Alzheimer's Disease

  2015cites this paper
• Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.

  2014cites this paper
• Alzheimer disease and platelets: how’s that relevant

  2012cites this paper
• Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals

  2012cites this paper
• Calpain Dysregulation in Alzheimer's Disease

  2012cites this paper
• Aβ toxicity in primary cultured neurons.

  2011cites this paper
• Alzheimer's disease: A Threat to mankind

  2011cites this paper
• New insights on Alzheimer's disease diagnostic.

  2011cites this paper
• Limbic System and the Temporal Lobe

  2011cites this paper
• Micronutrients in the Prevention and Improvement of the Standard Therapy for Alzheimer’s Disease

  2010cites this paper
• The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments.

  2009cites this paper
• The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons.

  2008cites this paper
• Association of NAD(P)H:Quinone Oxidoreductase 1 Polymorphism and Alzheimer’s Disease in Chinese

  2008cites this paper
• Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway.

  2007cites this paper
• Interaction between β-amyloid protein and the α 7 nicotinic acetylcholine receptor in cholinergic , gabaergic and calcium-binding proteins-containing neurons in the septum-diagonal band complex of the rat

  2007cites this paper
• Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.

  2007cites this paper
• BACE inhibitor reduces APP-β-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration

  2006cites this paper
• Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer’s type

  2006cites this paper
• Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.

  2006cites this paper
• Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat.

  2006cites this paper
• Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age.

  2005cites this paper
• The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration

  2005cites this paper
• Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

  2005cites this paper
• Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice

  2005cites this paper
• The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid.

  2005cites this paper
• Selenomethionine Prevents Degeneration Induced by Overexpression of Wild-Type Human α-Synuclein during Differentiation of Neuroblastoma Cells

  2005cites this paper
• Genetic causes of mental retardation

  2005cites this paper
• α1 integrin activation: A link between β‐amyloid deposition and neuronal death in aging hippocampal neurons

  2004cites this paper
• Long‐term efficacy and safety of galantamine in patients with mild‐to‐moderate Alzheimer's disease: multicenter trial

  2004cites this paper
• RADIOLABELLED THIOFLAVIN-T DERIVATIVES VO DIAGNOSIS OF PERIPH

  2004cites this paper
• Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

  2004cites this paper
• Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ

  2004cites this paper
• Overexpression of α‐synuclein decreased viability and enhanced sensitivity to prostaglandin E2, hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells

  2004influential citation
• Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells

  2003cites this paper
• Effects of β-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat

  2003cites this paper
• Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment

  2002cites this paper
• Tau is essential to β-amyloid-induced neurotoxicity

  2002cites this paper
• Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines

  2002cites this paper
• Alteration of cholinergic, excitatory amino acid and neuropeptide markers in the septum-diagonal band complex following injections of fibrillar ß-amyloid protein into the retrosplenial granular cortex of the rat.

  2002influential citation
• El receptor pepenador y su importancia en procesos amiloidóticos

  2002cites this paper
• Apolipoprotein A‐1‐derived amyloid in atherosclerotic plaques of the human aorta

  2001cites this paper
• Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.

  2001cites this paper
• Mitochondrial Function and Alzheimer’s Disease

  2001cites this paper
• The formation of PHF-1 and SMI-31 positive dystrophic neurites in rat hippocampus following acute injection of okadaic acid.

  2000cites this paper
• Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells.

  2000cites this paper
• PD98059 Prevents Neurite Degeneration Induced by Fibrillar β‐Amyloid in Mature Hippocampal Neurons

  2000cites this paper
• Relative sensitivity of undifferentiated and cyclic adenosine 3′, 5′-monophosphate-induced differentiated neuroblastoma cells to cyclosporin A: potential role of β-amyloid and ubiquitin in neurotoxicity

  2000cites this paper
• Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model

  2000cites this paper
• NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease.

  2000cites this paper
• β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model system

  2000cites this paper
• Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale.

  2000cites this paper
• Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study.

  1999cites this paper
• beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

  1999cites this paper
• Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid.

  1999cites this paper
• Clinical Profile of Donepezil in the Treatment of Alzheimer’s Disease

  1999cites this paper
• Adenosine 3′, 5′- Cyclic Monophosphate Increases Processing of Amyloid Precursor Protein (APP) to β-Amyloid in Neuroblastoma Cells Without Changing APP Levels or Expression of APP mRNA

  1999cites this paper
• Regulation of Amyloid Precursor Protein Secretion by Glutamate Receptors in Human Ntera 2 Neurons (NT2N)*

  1998cites this paper
• Category-Specific Semantic Deficits in Focal and Widespread Brain Damage: A Computational Account

  1998cites this paper
• Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

  1998cites this paper
• Prostaglandins as Putative Neurotoxins in Alzheimer's Disease

  1998cites this paper
• Alzheimer's disease. Cholinergic therapy and beyond.

  1998cites this paper
• Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and β-amyloid

  1998cites this paper
• Identification of septins in neurofibrillary tangles in Alzheimer's disease.

  1998cites this paper
• Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains.

  1998cites this paper
• In vivo MR spectroscopy of human dementia.

  1998cites this paper
• Role of APOE in Dementia:A Critical Reappraisal

  1998cites this paper
• Alzheimer's Syndrome and not Alzheimer's disease: The historical struggle to define the disease

  1998cites this paper
• The apolipoprotein E genotyping using the PCR-RFLP was useful to linkage analysis of Alzheimer's disease families

  1997cites this paper
• PrP and β‐Amyloid Fragments Activate Different Neurotoxic Mechanisms in Cultured Mouse Cells

  1997cites this paper
• Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging.

  1997cites this paper
• High density lipoprotein decreases β‐amyloid toxicity in cortical cell culture

  1997cites this paper
• Defective neurite extension is caused by a mutation in amyloid β/A4 (Aβ) protein precursor found in Familial Alzheimer's Disease

  1997cites this paper
• In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia.

  1997cites this paper
• Mechanisms of cell death in Alzheimer's disease.

  1997cites this paper
• Calcium Homeostasis and Free Radical Metabolism as Convergence Points in the Pathophysiology of Dementia

  1997cites this paper
• Integrin Mac-1 and β-amyloid in microglial release of nitric oxide

  1997cites this paper
• Basal forebrain amnesia

  1997cites this paper
• Alzheimer's disease: an overview for the pharmacist.

  1997cites this paper
• Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells

  1997cites this paper
• Linopirdine: Pharmacology of a Neurotransmitter Release Enhancer

  1997cites this paper
• Apolipoprotein Eϵ4 allele, a risk factor for late onset nonfamilial Alzheimer's disease among Israeli Jews

  1997cites this paper
• Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E correlatable defects

  1996cites this paper